Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cor H J Lamers

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Immunotherapy|July 9, 2013
Genetically modified T lymphocytes: more than just direct effectorsCor H J Lamers, Reno Debets
Stem Cell Investigation|June 14, 2017
Graft predominance after double umbilical cord blood transplantation: a reviewJan J Cornelissen, Burak Kalin, Cor H J Lamers
Immunotherapy|June 13, 2015
Adoptive T-cell therapy: a need for standard immune monitoringYarne Klaver, Andre Kunert, Stefan Sleijfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2017
T-cell Receptors for Clinical Therapy: <i>In Vitro</i> Assessment of Toxicity RiskAndre Kunert, Matthias Obenaus, Cor H J Lamers, et al.
Biochemical Society Transactions|June 11, 2016
Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overviewCor H J Lamers, Yarne Klaver, Jan W Gratama, et al.
Clinical Immunology (Orlando, Fla.)|July 6, 2016
Plasma IFN-γ and IL-6 levels correlate with peripheral T-cell numbers but not toxicity in RCC patients treated with CAR T-cellsYarne Klaver, Sabine C L van Steenbergen, Stefan Sleijfer, et al.
Frontiers in Immunology|January 14, 2017
T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in PatientsYarne Klaver, Sabine C L van Steenbergen, Stefan Sleijfer, et al.
Cancer Gene Therapy|June 26, 2002
Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancerCor H J Lamers, Ralph A Willemsen, Barbara A Luider, et al.
Cytometry. Part B, Clinical Cytometry|June 10, 2010
Levels of circulating endothelial cells in normotensive and severe preeclamptic pregnanciesMichiel H Strijbos, Claudia A Snijder, Jaco Kraan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectorsCor H J Lamers, Ralph A Willemsen, Pascal M M L van Elzakker, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Immunotherapy|July 9, 2013
Genetically modified T lymphocytes: more than just direct effectorsCor H J Lamers, Reno Debets
Stem Cell Investigation|June 14, 2017
Graft predominance after double umbilical cord blood transplantation: a reviewJan J Cornelissen, Burak Kalin, Cor H J Lamers
Immunotherapy|June 13, 2015
Adoptive T-cell therapy: a need for standard immune monitoringYarne Klaver, Andre Kunert, Stefan Sleijfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2017
T-cell Receptors for Clinical Therapy: <i>In Vitro</i> Assessment of Toxicity RiskAndre Kunert, Matthias Obenaus, Cor H J Lamers, et al.
Biochemical Society Transactions|June 11, 2016
Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overviewCor H J Lamers, Yarne Klaver, Jan W Gratama, et al.
Clinical Immunology (Orlando, Fla.)|July 6, 2016
Plasma IFN-γ and IL-6 levels correlate with peripheral T-cell numbers but not toxicity in RCC patients treated with CAR T-cellsYarne Klaver, Sabine C L van Steenbergen, Stefan Sleijfer, et al.
Frontiers in Immunology|January 14, 2017
T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in PatientsYarne Klaver, Sabine C L van Steenbergen, Stefan Sleijfer, et al.
Cancer Gene Therapy|June 26, 2002
Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancerCor H J Lamers, Ralph A Willemsen, Barbara A Luider, et al.
Cytometry. Part B, Clinical Cytometry|June 10, 2010
Levels of circulating endothelial cells in normotensive and severe preeclamptic pregnanciesMichiel H Strijbos, Claudia A Snijder, Jaco Kraan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectorsCor H J Lamers, Ralph A Willemsen, Pascal M M L van Elzakker, et al.
Pageof 3